Evoqua United States - Canada - EN

Evoqua Water Technologies Opens New Manufacturing Facility in Singapore to Support Growth in APAC

New facility focused on manufacturing innovative water solutions to support demand in APAC markets

PITTSBURGH, PA & SINGAPORE – Evoqua Water Technologies (NYSE: AQUA), a leader in mission-critical water treatment solutions, recently celebrated the opening of its new manufacturing facility based in Singapore, furthering the company's investment in Asia-Pacific (APAC) as demand continues to grow for innovative water treatment solutions in the region.

The 19,000 square foot state-of-the-art facility will be the global manufacturing facility for Evoqua's Ionpure® Continuous Electrodeionization (CEDI) products. Evoqua's Ionpure brand was the first to commercialize CEDI for water purification, a chemical-free, self-regenerating technology that provides a consistent flow of high-quality deionized water.

The new facility supports efforts to localize production to better serve the increasing demand for ultrapure water solutions in the APAC region, predominately in the microelectronics and pharmaceutical industries. The new facility is expected to bring approximately 30 jobs to the region.

"The establishment of this new manufacturing facility supports Evoqua's growth and market development plans for the Asia-Pacific market," said Ron Keating, Evoqua's Chief Executive Officer. "Our expanded presence allows us to meet the growing needs of the APAC market, strengthening our commitment to helping our customers across the region address their critical water treatment needs."

To inaugurate the event, Mr. Keating was joined by Hervé Fages, Evoqua's Executive Vice President and Applied Product Technologies Segment President, for the ceremonial ribbon-cutting event hosted on June 7, 2022.


Ron Keating, Evoqua's Chief Executive Officer (right), was joined by Govindan Alagappan, Evoqua's VP and Managing Director for APAC (left), Hervé Fages, Evoqua's Executive Vice President and Applied Product Technologies Segment President (center left), and Keng Hoo Yeo, Operations Director for Evoqua (center right).

About Evoqua Water Technologies

Evoqua Water Technologies is a leading provider of mission critical water and wastewater treatment solutions, offering a broad portfolio of products, services and expertise to support industrial, municipal and recreational customers who value water. Evoqua has worked to protect water, the environment and its employees for more than 100 years, earning a reputation for quality, safety and reliability around the world. Headquartered in Pittsburgh, Pennsylvania, the company operates in more than 150 locations across nine countries. Serving more than 38,000 customers and 200,000 installations worldwide, our employees are united by a common purpose: Transforming Water. Enriching Life®.


DESOTEC, founded in 1990, is the leading European provider of mobile filtration solutions through a unique and circular service concept, which helps protect the planet by enabling clean water, air, and soil. DESOTEC's customer base is constantly growing thanks to a strong focus on 24/7 service and a commitment to design and deliver the best solution in close dialogue with the customer. Through in-depth expertise of industrial applications and continuous investment in mobile filters, reactivation capacity and well-positioned hubs, DESOTEC ensures that the industry can meet the increasing regulations for a better and cleaner environment. Private equity funds managed by Blackstone acquired DESOTEC in 2021. Further information is available at www.desotec.com.

About Blackstone

Blackstone is the world’s largest alternative asset manager. We seek to create positive economic impact and long-term value for our investors, the companies we invest in, and the communities in which we work. We do this by using extraordinary people and flexible capital to help companies solve problems. Our $951 billion in assets under management include investment vehicles focused on private equity, real estate, public debt and equity, infrastructure, life sciences, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds, all on a global basis. Further information is available at www.blackstone.com.